Literature DB >> 11843961

Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study.

M Asaka1, T Sugiyama, A Nobuta, M Kato, H Takeda, D Y Graham.   

Abstract

BACKGROUND: This study evaluated the relationship between Helicobacter pylori infection, atrophic gastritis and intestinal metaplasia in Japan.
MATERIALS AND METHODS: This was a multicenter study performed in 21 centers in Japan. A total of 2455 individuals were enrolled. H. pylori status was determined by validated ELISAs. Atrophic gastritis was diagnosed by histology, endoscopy with Congo Red dye scattering or the Kimura-Takemoto endoscopic classification.
RESULTS: Atrophic gastritis increased from 9.4% in those less than 20 years of age to > 70% in those aged 60 or older and was strongly associated with H. pylori infection. The overall prevalence of atrophic gastritis in H. pylori infection was 82.9% (1272/1534) compared with 9.8% (90/921) among uninfected (OR = 44.8; 95% CI = 34.7-57.8). Intestinal metaplasia was present in 43.1% (542/1258) of H. pylori positive persons compared with 6.2% (51/823) among the uninfected (OR = 11.5; 95% CI = 8.5-15.5). Atrophic gastritis in H. pylori positive Japanese was very high in the younger generation (38.5% in those aged 20 or less and 58.5% in those 21-30).
CONCLUSIONS: Atrophic gastritis and intestinal metaplasia were strongly associated with H. pylori and not with aging. The fall in prevalence of H. pylori in Japan has not been associated with a corresponding fall in the prevalence of atrophic gastritis among those with H. pylori infection. The high prevalence of the precursor lesion, atrophic gastritis with intestinal metaplasia, among those with H. pylori infection suggests that the risk of development of early gastric cancer will continue to remain high in Japan.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843961     DOI: 10.1046/j.1523-5378.2001.00042.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  59 in total

1.  Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection.

Authors:  Sohachi Nanjo; Kiyoshi Asada; Satoshi Yamashita; Takeshi Nakajima; Kazuyuki Nakazawa; Takao Maekita; Masao Ichinose; Toshiro Sugiyama; Toshikazu Ushijima
Journal:  Gastric Cancer       Date:  2012-01-12       Impact factor: 7.370

2.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

3.  Strategy for eliminating gastric cancer in Japan.

Authors:  Masahiro Asaka; Mototsugu Kato; David Y Graham
Journal:  Helicobacter       Date:  2010-12       Impact factor: 5.753

4.  High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA.

Authors:  Christie E Choi; Amnon Sonnenberg; Kevin Turner; Robert M Genta
Journal:  Dig Dis Sci       Date:  2015-02-28       Impact factor: 3.199

5.  Helicobacter pylori and colorectal neoplasm: a mysterious link?

Authors:  Hiroshi Takeda; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

6.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

7.  Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus.

Authors:  Tan Han Loong; Ngiu Chai Soon; Nik Ritza Kosai Nik Mahmud; Jeevinesh Naidu; Rafiz Abdul Rani; Nazefah Abdul Hamid; Marjanu Hikmah Elias; Isa Mohamed Rose; Azmi Tamil; Norfilza M Mokhtar; Raja Affendi Raja Ali
Journal:  Biomed Rep       Date:  2017-09-20

8.  Inducible nitric oxide synthase polymorphism is associated with the increased risk of differentiated gastric cancer in a Japanese population.

Authors:  Yasuyuki Goto; Takafumi Ando; Mariko Naito; Hidemi Goto; Nobuyuki Hamajima
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Firm measures are required to effect any significant decrease in the Japanese age-adjusted mortality rate from malignant neoplasms for the 21st century.

Authors:  Shigeyuki Nakaji; Qiang Liu; Tatsuya Yamamoto; Yukika Kakuta; Juichi Sakamoto; Kazuo Sugawara; John C Bailar
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Prevalence of subjects at a high or very high risk of gastric cancer in Japan.

Authors:  Miyoko Yamaoka; Shigemi Nakajima
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.